Search Results - P Tappenden

  • Showing 1 - 10 results of 10
Refine Results
  1. 1

    Systematic review and economic evaluation of bevacizumab and cetuximab for the treatment of metastatic colorectal cancer by P Tappenden, R Jones, S Paisley, C Carroll

    Published in Health Technology Assessment (2007-03-01)
    Get full text
    Article


  2. 2

    Varenicline in the management of smoking cessation: a single technology appraisal by D Hind, P Tappenden, J Peters, K Kenjegalieva

    Published in Health Technology Assessment (2009-09-01)
    Get full text
    Article


  3. 3

    The clinical and cost-effectiveness of oxaliplatin and capecitabine for the adjuvant treatment of colon cancer: systematic review and economic evaluation by A Pandor, S Eggington, S Paisley, P Tappenden, P Sutcliffe

    Published in Health Technology Assessment (2006-11-01)
    Get full text
    Article


  4. 4

    The clinical effectiveness and cost-effectiveness of pioglitazone for type 2 diabetes mellitus: a rapid and systematic review by J. Chilcott, J. Wight, M. Lloyd Jones, P. Tappenden

    Published in Health Technology Assessment (2001-01-01)
    Get full text
    Article


  5. 5

    Methods for expected value of information analysis in complex health economic models: developments on the health economics of interferon-β and glatiramer acetate for multiple scler... by P Tappenden, J Chilcott, S Eggington, J Oakley, C McCabe

    Published in Health Technology Assessment (2004-06-01)
    Get full text
    Article


  6. 6

    The use of irinotecan, oxaliplatin and raltitrexed for the treatment of advanced colorectal cancer: systematic review and economic evaluation by D Hind, P Tappenden, I Tumur, S Eggington, P Sutcliffe, A Ryan

    Published in Health Technology Assessment (2008-05-01)
    Get full text
    Article


  7. 7

    Colistimethate sodium powder and tobramycin powder for inhalation for the treatment of chronic Pseudomonas aeruginosa lung infection in cystic fibrosis: systematic review and econo... by P Tappenden, S Harnan, L Uttley, M Mildred, C Carroll, A Cantrell

    Published in Health Technology Assessment (2013-12-01)
    Get full text
    Article


  8. 8

    Amantadine, oseltamivir and zanamivir for the prophylaxis of influenza (including a review of existing guidance no. 67): a systematic review and economic evaluation by P Tappenden, R Jackson, K Cooper, A Rees, E Simpson, R Read, K Nicholson

    Published in Health Technology Assessment (2008-02-01)
    Get full text
    Article


  9. 9

    Avoiding and identifying errors in health technology assessment models: qualitative study and methodological review by J Chilcott, P Tappenden, A Rawdin, M Johnson, E Kaltenthaler, S Paisley, D Papaioannou, A Shippam

    Published in Health Technology Assessment (2010-05-01)
    Get full text
    Article


  10. 10

    The clinical effectiveness and cost-effectiveness of cetuximab (mono- or combination chemotherapy), bevacizumab (combination with non-oxaliplatin chemotherapy) and panitumumab (mon... by M Hoyle, L Crathorne, J Peters, T Jones-Hughes, C Cooper, M Napier, P Tappenden, C Hyde

    Published in Health Technology Assessment (2013-04-01)
    Get full text
    Article


Search Tools: